2013年1月24日星期四

Quitting smoking prolongs life at any age


It's never too late to quit smoking, and researchers have new data to prove it. Even at the age of 64, kicking the habit can add four years to a person's life, while quitting by age 34 can increase life expectancy by a decade, according to a study published online Wednesday by the New England Journal of Medicine.

After analyzing health data from more than 200,000 Americans, researchers calculated that current smokers were three times more likely to die during the course of the study compared with people who had never smoked. For the most part, their deaths were caused by smoking-related ailments, including heart and lung disease. Overall, their odds of surviving to age 80 were half as good as for never-smokers.

But the study, one of two large-scale surveys in the journal providing updated information on smoking and mortality, saw significant benefits for those who quit. Giving up smoking between the ages of 35 and 44 was associated with a gain of nine years of life, and those who quit between 45 and 54 lived an extra six years.

"The good news is, because the risks are so big, the benefits of quitting are quite substantial," said study leader Prabhat Jha, an epidemiologist and director of the Center for Global Health Research, based in Toronto.

While the U.S. smoking rate has declined to 19.3% among adults, there are still an estimated 45.3 million smokers in this country, according to the Centers for Disease Control and Prevention. Cigarette use is responsible for about 443,000 U.S. deaths each year, the CDC says.

Using the National Health Interview Survey, the researchers followed 113,752 women and 88,496 men in the U.S. between 1997 and 2004, categorizing them as smokers (at least 100 cigarettes within their lifetime), former smokers (no smoking within the last five years) and never-smokers. Former smokers were held to the five-year rule in order to weed out those who were already in declining health because of potentially fatal smoking-related diseases.

The researchers checked death records in 2006 and found that 8,236 of the women and 7,479 of the men had died. By comparing mortality rates among the groups, Jha's team calculated that women between the ages of 25 and 79 who were current smokers were three times more likely to die than women who never smoked. Among men in that age group, those who still smoked were 2.8 times more likely to die than never-smokers. The results were adjusted for age, education, body mass index and alcohol consumption, since smokers tended to be thinner, have less education and be more likely to drink.

The vast difference in mortality rates is partly due to the increasing health standards of the nonsmoking population, Jha said.

The second study examined mortality rates over half a century in 2.2 million people 55 and older — possibly the largest such survey undertaken, said lead author Michael Thun, recently retired from his work as a cancer epidemiologist with the American Cancer Society.

Thun's survey measured trends in death rates across three time periods: 1959 to 1965, 1982 to 1988 and 2000 to 2010.

The analysis revealed a worrying trend that also cropped up in Jha's study: Women's death rates from smoking, which had long lagged behind men's, had pulled even.

Consider lung cancer. In the early 1960s, women smokers were 2.73 times more likely to die from lung cancer than their nonsmoking counterparts; by 2010, they were 25.66 times more likely to die of the disease, Thun found. (Male smokers' relative risk of dying of lung cancer rose from 12.22 to 24.97 over the same period.)

"It's staggering," Thun said.

It's an unsurprising glass ceiling to break, doctors said. Women began smoking routinely after World War II, about two decades after men took up the habit, so it was only a matter of time until their mortality rates caught up.

The two papers did not draw distinctions between people who smoked a pack a day and those who might smoke just a few cigarettes a day, said Dr. Steven Schroeder, director of the Smoking Cessation Leadership Center at UC San Francisco. A next step in terms of study would be "to find out how much less health problems there are for smokers who smoke fewer cigarettes," he said.

Taken together, the studies point to a need for far more effective efforts to reach potential and current smokers, Schroeder added.

The message needs to get out to young and old smokers alike, he said: "There's a ray of hope. It's never too late to quit."

2013年1月23日星期三

Putting a Number on Smoking’s Toll


It is often said that smoking takes years off your life, and now a new study shows just how many: Longtime smokers can expect to lose about 10 years of life expectancy.

But amid those grim findings was some good news for former smokers. Those who quit before they turn 35 can gain most if not all of that decade back, and even those who wait until middle age to kick the habit can add about five years back to their life expectancies.

“There’s the old saw that everyone knows smoking is bad for you,” said Dr. Tim McAfee of the Centers for Disease Control and Prevention. “But this paints a much more dramatic picture of the horror of smoking. These are real people that are getting 10 years of life expectancy hacked off — and that’s just on average.”

The findings were part of research, published on Wednesday in The New England Journal of Medicine, that looked at government data on more than 200,000 Americans who were followed starting in 1997. Similar studies that were done in the 1980s and the decades prior had allowed scientists to predict the impact of smoking on mortality. But since then many population trends have changed, and it was unclear whether smokers today fared differently from smokers decades ago.

Since the 1960s, the prevalence of smoking over all has declined, falling from about 40 percent to 20 percent. Today more than half of people that ever smoked have quit, allowing researchers to compare the effects of stopping at various ages.

Modern cigarettes contain less tar and medical advances have cut the rates of death from vascular disease drastically. But have smokers benefited from these advances?

Women in the 1960s, ’70s and ’80s had lower rates of mortality from smoking than men. But it was largely unknown whether this was a biological difference or merely a matter of different habits: earlier generations of women smoked fewer cigarettes and tended to take up smoking at a later age than men.

Now that smoking habits among women today are similar to those of men, would mortality rates be the same as well?

“There was a big gap in our knowledge,” said Dr. McAfee, an author of the study and the director of the C.D.C.’s Office on Smoking and Public Health.

The new research showed that in fact women are no more protected from the consequences of smoking than men. The female smokers in the study represented the first generation of American women that generally began smoking early in life and continued the habit for decades, and the impact on life span was clear. The risk of death from smoking for these women was 50 percent higher than the risk reported for women in similar studies carried out in the 1980s.

“This sort of puts the nail in the coffin around the idea that women might somehow be different or that they suffer fewer effects of smoking,” Dr. McAfee said.

It also showed that differences between smokers and the population in general are becoming more and more stark. Over the last 20 years, advances in medicine and public health have improved life expectancy for the general public, but smokers have not benefited in the same way.

“If anything, this is accentuating the difference between being a smoker and a nonsmoker,” Dr. McAfee said.

The researchers had information about the participants’ smoking histories and other details about their health and backgrounds, including diet, alcohol consumption, education levels and weight and body fat. Using records from the National Death Index, they calculated their mortality rates over time.

People who had smoked fewer than 100 cigarettes in their lifetimes were not classified as smokers. Those who had smoked at least 100 cigarettes but had not had one within five years of the time the data was collected were classified as former smokers.

Not surprisingly, the study showed that the earlier a person quit smoking, the greater the impact. People who quit between 25 and 34 years of age gained about 10 years of life compared to those who continued to smoke. But there were benefits at many ages. People who quit between 35 and 44 gained about nine years, and those who stopped between 45 and 59 gained about four to six years of life expectancy.

From a public health perspective, those numbers are striking, particularly when juxtaposed with preventive measures like blood pressure screenings, colorectal screenings and mammography, the effects of which on life expectancy are more often viewed in terms of days or months, Dr. McAfee said.

“These things are very important, but the size of the benefit pales in comparison to what you can get from stopping smoking,” he said. “The notion that you could add 10 years to your life by something as straightforward as quitting smoking is just mind boggling.”

2013年1月22日星期二

Pacific Life Insurance Company Announces Early Settlement of Tender Offer


Pacific Life Insurance Company (“Pacific Life”) today announced the exercise of its early settlement right for all of its 9.25% Surplus Notes due 2039 (the “Notes”) tendered at or prior to the early tender time in connection with its previously announced cash tender offer. $322,793,000 aggregate principal amount of the Notes were tendered by the early tender time, which was 5:00 p.m., New York City time, on January 15, 2013.

All of such tendered Notes were accepted for payment and settlement was made on January 22, 2013.
Holders of the $322,793,000 aggregate principal amount of Notes that have been accepted for purchase will receive the Full Tender Offer Consideration (as defined in the Offer to Purchase described below), which amounts to a total of $1,478.68 per $1,000 principal amount of the Notes, plus accrued and unpaid interest.

The terms and conditions of the offer are described in the offer to purchase, dated January 2, 2013 (the “Offer to Purchase”) and the related letter of transmittal (the “Letter of Transmittal” and, together with the Offer to Purchase, the “Offer Documents”) sent to holders of the Notes. The offer will expire at 11:59 p.m., New York City time, on January 30, 2013, unless extended or earlier terminated by Pacific Life.

2013年1月21日星期一

Life Insurance a Priority for Those With Dependents


January is naturally a time when a lot of people take stock of their situations in life. They take a step back and determine whether they are happy in their relationships, whether they are happy in their professional circumstances, their current living circumstances, and so on. The team at Lifebroker wants to make sure that people draft life insurance into this annual evaluation.

Life insurance is no superfluous expense. The raison d'etre for life insurance is to give the policy holder peace of mind as far as their dependents are concerned. Nobody can predict the future and as such it makes sense for consumers to prepare for the worst, however expected or unexpected it happens to be.

A suitable life insurance policy will cover the holder in the event of their death and it will provide the necessary financial support for the dependents left behind. This is extremely important for homeowners and others who have outgoings that will need to be covered even after they pass away.

Life insurance comes in all sorts of shapes and forms. There are policies designed especially for people who are over 50, life insurance policies designed for couples, life insurance policies designed for people with specific illnesses, mortgage protection schemes for homeowners and many more varieties besides.
People who take a look at their personal circumstances in January and decide they need some form of life insurance policy are advised to speak to a professional life insurance broker in order to make sure they get a good deal on a policy that provides the right sort of cover for them.

Lifebroker is the UK's leading online life insurance broker operating wholly online through its website http://www.lifebroker.co.uk. The site offers fast, free and secure comparisons for life insurance policies of all kinds from some of the leading insurance companies.

Bear of the Day: China Life Insurance


We are downgrading our recommendation on China Life Insurance (LFC) to Underperform based on the constant decline in operating cash flow, which is affecting the financials. The gradual decline in premiums and increasing competition on the domestic front are the other downsides.

The company also faces substantial interest rate and currency risks, which limit upside. China Life also reported a net loss in the third quarter, due to a surge in operating expenses, which offset the operating income increases.

The company has a strong brand name, an extensive domestic distribution channel, strong investments and stable ratings. However, our six-month target price of $46.00 equates to 48.4x our earnings estimate for 2012. Combined with the $0.55 per ADR annual dividend, this target price implies an expected negative return of 9.4% over that period.

2013年1月18日星期五

Life Time Fitness Named Racquet Sport's Industry's Private Facility of the Year


The Healthy Way of Life Company (NYSE: LTM) has been named Racquet Sport’s Industry’s ‘Private Facility of the Year’ as part of the magazine’s annual ‘Champions of Tennis’ awards. Life Time is America’s largest manager of indoor tennis facilities, where 16 of its 105 centers have dedicated tennis courts and programs. The award is recognition of Life Time’s investment in the game of tennis through its Places, People, and Programs.

In February 2012, Life Time announced it had acquired Atlanta, Georgia-based Racquet Club of the South (RCS), expanding its tennis operations to 158 courts and 211 Certified Tennis Professionals nationwide and becoming the largest national operator of indoor tennis courts with 104. Racquet Club of the South has since been rebranded as Life Time Athletic at Peachtree Corners and is undergoing renovation to become a world-class health and fitness facility and Life Time’s Southeast hub for junior tennis champion training, coaching and development, and recreational play and instruction.

“We are honored to be recognized as Racquet Sport’s Industry’s ‘Private Facility of the Year’,” says Layne McCleary, senior manager of National Tennis Operations at Life Time. “Tennis has been part of a developing vision for Life Time and will continue to be as we incorporate tennis into new Life Time destinations and focus on providing social and competitive tennis opportunities for our members.”

According to the January 2013 issue of Racquet Sports Industry magazine, Life Time received this award for its full complement of tennis programs and services, online and in-person tennis communities and continued vision forward including added budget to improve tennis facilities, programs and services.

2013年1月17日星期四

Life Science Veterans Highlight Opportunities at BIOCOM 3rd Annual Global Partnering Conference


BIOCOM, the Southern California Life Science Association representing over 550 member companies, announced today the 26 life science professionals who will speak at the 3rd Annual Global Life Science Partnering Conference on February 27-28 at The Lodge at Torrey Pines. The conference is an exclusive global partnering and networking forum that brings together senior executives and business development professionals from leading pharmaceutical and biotech companies.

"The BIOCOM 3rd Annual Global Life Science Partnering Conference will feature an impressive line-up of speakers to provide insights and expertise that will be valuable for the life science community. We expect this event to generate rich dialogue and provide direct interactions for executives who are responsible for facilitating partnerships to advance their businesses," said Senior Vice President and Chief Operating Officer, Jennifer Landress of BIOCOM.

Keynote sessions include Bill Rastetter, Ph.D., Partner at Venrock interviewed by Mark Wiggins, SVP Business Development at Elcelyx Therapeutics, in a fireside chat on "Reflections on the Unexpected" and John C. Reed, M.D., Ph.D., who will soon join Roche after serving for the past 11 years as Faculty Member and CEO of Sanford-Burnham Medical Research Institute.

The speakers for the Business Development Panel include Marty Birkhofer, M.D., Vice President of the Strategic Transactions Group at Bristol-Myers Squibb; Brian McVeigh, Vice President of WWBD Transactions and Investment Management at GlaxoSmithKline Pharmaceuticals; Tony Rosenberg, Head of Global BD & Licensing at Novartis; and Barbara Yanni, J.D., L.L.M., C.L.P., Vice President and Chief Licensing Officer at Merck.
There will be a CEO Panel at 8:30AM on February 28th focusing on "Building a Successful New Company" featuring Alain Baron, M.D., President & CEO, Director at Elcelyx Therapeutics; Dan Burgess, President & CEO at Rempex Pharmaceuticals; Rich Heyman, Ph.D., President and CEO at Aragon Pharmaceuticals; and Gonul Velicelebi, Ph.D., Founder, President and CEO at CalciMedica.

At 12:15PM on February 28th, there will be another senior executive panel discussing "Trends in Business Development" featuring Richard Brudnick, Vice President and Co-Head of Business Development at Biogen-Idec; George S. Golumbeski, Ph.D., SVP of Business Development at Celgene Corporation; Iain Dukes, Vice President of External Research and Development at Amgen; and Rob Wills, Ph.D., Vice President of Alliance Management at Johnson & Johnson.

The last panel of the conference will be focusing on "Venture Financing" and will include Corey Goodman, Ph.D., Managing Partner and Co-Founder at venBIO LLC; David Kabakoff, Ph.D., Executive Partner at Sofinnova Ventures; Carole Nuechterlein, Head at Roche Venture Fund; Heather Preston, M.D., Managing Director at TPG Biotechnology; and James Topper, M.D., Ph.D., General Partner at Frazier Healthcare.

Additional presenters include: Kleanthis Xanthopoulos, Ph.D., President and CEO of Regulus Therapeutics speaking about "Going Public in a Challenging Environment;" Kurt Graves, Chairman & CEO of Intarcia Therapeutics, Inc.; Lewis Geffen, Co-Chair of the VC and Emerging Companies Practice at Mintz, Levin, Cohn, Ferris, Glovsky and Popeo; and Michael Ross, Ph.D., Managing Partner at SV Life Sciences.

The conference will take place inside the Lodge at Torrey Pines from 7:30AM – 7:30PM on both days and will include breakfast, one-on-one partnering meetings, individual company presentations, senior executive panels, a networking lunch and end with a gala reception.